Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Foot ulcers are common among the 30 million Americans suffering from diabetes. They’re the main cause of lower limb amputations, according to the Centers for Disease Control. With diabetes projected to rise to half a billion people worldwide, the need for improved screening and earlier intervention in diabetic foot disease is critical.

That’s why we’re learning about the importance of early intervention, and how an innovative screening device from HyperMed Imaging can potentially help patients stay one step ahead.

HyperMed Imaging, Inc. is the established leader in medical hyperspectral imaging for surface tissue oximetry. Their pioneering technology has been in service since 2006 and has been shown in published clinical research to effectively assess oxyhemoglobin, deoxyhemoglobin, and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications.

By imaging oxyhemoglobin and deoxyhemoglobin levels, as well as oxygen saturation in superficial tissue, the device provides clinicians a new understanding of perfusion, thereby leading to more informed treatment decisions. Applications include wound care, vascular care, reconstructive surgery, and limb preservation, among others. Stay tuned to learn more.

Vivos Therapeutics is helping those with obstructive sleep apnea breathe new life with a whole-body approach. They’re an evidence-driven healthcare company with a dedicated mission to address obstructive sleep apnea worldwide.

Stay tuned for another episode of The Balancing Act, where we're covering everything from innovative medical advancements to trendy New York City destinations.

Looking for a way to ease the burden of prescription refills? Enter Simplefill, a full-service prescription assistance program that helps members afford their medications.

Comments

comments